Three innovative companies have been shortlisted for a Femtech World Award.
Now in its second year, the Femtech World Awards celebrate some of the best examples of leadership, innovation and impact in key areas that affect women’s health and wellbeing.
The Company of the Year award recognises an outstanding organisation that has demonstrated exceptional innovation, impact and leadership in the female technology sector.
The award is sponsored by Femovate: the global femtech incubator for early stage women’s health startups.
Femovate provides award winning product strategy and design to promising early stage femtech startups to advance innovation in women’s health.
A winner from the shortlist will be chosen by the sponsor and announced at a virtual ceremony on May 28.
Congratulations to the shortlisted organisations and thank you to everyone who entered.
Company of the Year Shortlist
Future Family is America’s leading platform for starting a family, solving one of the biggest barriers to fertility care: cost.
While IVF is a medical necessity for many, it remains financially out of reach, with costs exceeding $20,000 per cycle and no guarantee of success.
Future Family has helped over 10,000 families by extending $200M+ in credit, offering flexible fertility financing, and—most notably—launching the first-ever nationwide IVF insurance policy in the U.S. in February 2025.
This historic policy ensures that families either have a Baby or Money Back, removing the financial uncertainty that has long-defined fertility care.
Hinge Health is revolutionising care for people who face musculoskeletal disorders.
In particular, the company has set out to address the long-standing gaps in treatment that women receive for pelvic health conditions and menopause symptoms.
With a nationally-available Women’s Pelvic Health program, Hinge Health has expanded access to high-quality, clinically-backed care for women.
With a proven track record of reducing chronic pelvic pain by 53 per cent and broadening access to care, the company aims to set a new standard for women’s health.
In today’s complex societal and political environment, accessing essential reproductive and women’s healthcare services has become increasingly challenging.
From legislative restrictions to economic barriers, individuals face numerous obstacles when seeking reproductive care.
These hurdles often result in fragmented, costly, and inefficient healthcare experiences, jeopardizing progress and setting the clock back decades.
Progyny recognises this urgency, providing a women’s health solution that effectively bridges the gap between employers, patients and providers.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.
